niacinamide and transforming growth factor beta

niacinamide has been researched along with transforming growth factor beta in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's4 (15.38)29.6817
2010's18 (69.23)24.3611
2020's3 (11.54)2.80

Authors

AuthorsStudies
Shockett, P; Stavnezer, J1
Astier, A; Bertrand, C; Jacob, C; Lagente, V; Martin-Chouly, CA; Pruniaux, MP1
Heldin, CH; Ostman, A; Pietras, K; Rubin, K1
Angelotti, U; Antonaci, S; Fransvea, E; Giannelli, G1
Aburatani, H; Hirakawa, K; Iwata, C; Johansson, E; Kano, MR; Kiyono, K; Komuro, A; Matsumoto, Y; Miyazono, K; Miyoshi, H; Morishita, Y; Shirai, YT; Suzuki, HI; Watanabe, A; Yashiro, M1
Caja, L; Campbell, JS; Fabregat, I; Fausto, N; Fernández-Rodriguez, CM; Fernando, J; Lledó, JL; Sancho, P1
Alsinet, C; Barretina, J; Bruix, J; Cabellos, L; Friedman, SL; Hoshida, Y; Lachenmayer, A; Llovet, JM; Mazzaferro, V; Minguez, B; Newell, P; Savic, R; Schwartz, M; Thung, S; Toffanin, S; Tsai, HW; Villanueva, A; Ward, SC1
Feng, M; Liu, X; Wang, Q; Wang, Z; Yu, T; Yuan, Y; Zhuang, H1
Hui, KM; Ooi, LL; Xia, H1
Dufour, JF; Erös de Bethlenfalva-Hora, C; Geier, A; Kettenbach, J; Mertens, JC; Piguet, AC; Schmitt, J; Terracciano, L; Weimann, R1
Chen, CL; Dooley, S; Feldman, D; French, SW; Jeong, JH; Kashiwabara, C; Liu, JC; Machida, K; Mishra, L; Petrovic, L; Sher, L; Tsukamoto, H1
Noguchi, S; Takizawa, H; Yamauchi, Y1
Aoyagi, Y; Fujimaki, S; Hirose, Y; Kobayashi, T; Kubota, M; Matsuda, Y; Osawa, M; Sakata, J; Takamura, M; Wakai, T; Yamagiwa, S1
Alvarez-Barrientos, A; Bertran, E; Cepeda, EB; Fabra, À; Fabregat, I; Fernández-Rodríguez, CM; Fernández-Salguero, P; Fernando, J; Giannelli, G; Malfettone, A; Raimondi, G; Sancho, P; Vilarrasa-Blasi, R1
Chen, Z; Duan, Z; Fu, R; Ge, H; Gui, B; Han, J; Jia, L; Ma, X; Ou, Y; Tian, L; Wang, L1
Llovet, JM; Torrecilla, S1
Bandukwala, H; Belsúe, V; Casares, N; Coffer, PJ; Durántez, M; Gorraiz, M; Hervás-Stubbs, S; Lasarte, JJ; Lourenço, AR; Lozano, T; Oyarzábal, J; Prieto, J; Riezu-Boj, JI; Ruiz, M; Sarobe, P; Villanueva, L1
Chen, YL; Ding, X; Gao, Z; Gu, T; Liu, W; Qu, M; Wang, W; Wu, X; Xu, L; Zhang, W1
Han, C; Ungerleider, N; Wu, T; Yao, L; Zhang, J1
Choi, HJ; Han, Z; Joo, Y; Kang, D; Oh, GH; Song, JJ1
Antarianto, RD; Arozal, W; Louisa, M; Rahmaniah, R; Soetikno, V; Yuyuntia, Y1
Huang, Y; Jiang, R; Jiang, X; Li, X; Ling, W; Pang, N; Pei, L; Qiu, Y; Wan, T; Wang, S; Yang, H; Yang, L; Ye, M; Zhang, Z; Zhou, Y1
Cai, J; Dong, Z; Liu, Z; Shu, S; Tang, C; Wang, Y; Zheng, M1
Goto, S; Jingu, K; Li, TS; Xu, Y; Zhai, D; Zhang, X1
Dang Le, Q; Kuncorojakti, S; Osathanon, T; Pavasant, P; Rodprasert, W; Sawangmake, C1
Chen, M; Chen, Y; Ding, Y; Fang, EF; Gu, Y; Hu, Q; Li, Q; Li, W; Pang, N; Pei, L; Sun, Y; Xiao, Y; Yang, L; Ye, M; Zhang, Z; Zhou, Y1

Reviews

3 review(s) available for niacinamide and transforming growth factor beta

ArticleYear
High interstitial fluid pressure - an obstacle in cancer therapy.
    Nature reviews. Cancer, 2004, Volume: 4, Issue:10

    Topics: Alprostadil; Animals; Antineoplastic Agents; Biological Transport; Bradykinin; Extracellular Fluid; Humans; Hyaluronoglucosaminidase; Hydrostatic Pressure; Mice; Neoplasms; Niacinamide; Platelet-Derived Growth Factor; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2004
Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition.
    Recent patents on inflammation & allergy drug discovery, 2014, Volume: 8, Issue:1

    Topics: Airway Remodeling; Animals; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Inflammation Mediators; Lung; Lung Diseases; Myofibroblasts; Niacinamide; Patents as Topic; Phenylurea Compounds; Protein Kinase Inhibitors; Respiratory Mucosa; Sorafenib; Stromal Cells; Transforming Growth Factor beta

2014
New molecular therapies for hepatocellular carcinoma.
    Clinics and research in hepatology and gastroenterology, 2015, Volume: 39 Suppl 1

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Fibroblast Growth Factors; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins p21(ras); Signal Transduction; Sorafenib; Transforming Growth Factor beta

2015

Other Studies

23 other study(ies) available for niacinamide and transforming growth factor beta

ArticleYear
Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching.
    Journal of immunology (Baltimore, Md. : 1950), 1993, Dec-15, Volume: 151, Issue:12

    Topics: Animals; B-Lymphocytes; Cell Line; Chromosome Mapping; Cyclic AMP; Gene Rearrangement, B-Lymphocyte; Immunoglobulin A; Immunoglobulin Switch Region; In Vitro Techniques; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Transforming Growth Factor beta; Xanthines

1993
Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
    Life sciences, 2004, Jul-02, Volume: 75, Issue:7

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Azepines; Blotting, Western; Bronchodilator Agents; Carboxylic Acids; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Therapy, Combination; Fibroblasts; Humans; Isoenzymes; Lung; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Metalloproteases; Niacinamide; Nitriles; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2004
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:5

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Transforming Growth Factor beta

2008
Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Journal of the National Cancer Institute, 2009, Apr-15, Volume: 101, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Immunohistochemistry; Lentivirus Infections; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Niacinamide; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Smad2 Protein; Sorafenib; Stomach Neoplasms; Thrombospondin 1; Transforming Growth Factor beta; Transplantation, Heterologous; Vascular Endothelial Growth Factor A

2009
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
    Journal of cellular physiology, 2012, Volume: 227, Issue:4

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autocrine Communication; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Knockdown Techniques; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins; Pyridines; Signal Transduction; Sorafenib; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2012
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Sep-15, Volume: 18, Issue:18

    Topics: Animals; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cluster Analysis; Female; Gene Expression Profiling; Genomics; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Reproducibility of Results; Sorafenib; Transforming Growth Factor beta; Wnt Proteins; Wnt Signaling Pathway

2012
Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
    Journal of surgical oncology, 2013, Volume: 107, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Leukocytes, Mononuclear; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Signal Transduction; Sorafenib; T-Lymphocytes, Regulatory; Transforming Growth Factor beta

2013
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Smad7 Protein; Sorafenib; Transforming Growth Factor beta; Up-Regulation

2013
Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
    Clinical science (London, England : 1979), 2014, Volume: 126, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Hepatocyte Growth Factor; Interleukin-10; Liver Neoplasms, Experimental; Macrophages; Niacinamide; Phenylurea Compounds; Rats; Sorafenib; T-Lymphocytes; Transforming Growth Factor beta; Vascular Endothelial Growth Factors

2014
Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    The Journal of clinical investigation, 2013, Volume: 123, Issue:7

    Topics: AC133 Antigen; Adaptor Proteins, Signal Transducing; Animals; Antigens, CD; Antineoplastic Agents; Base Sequence; Carcinoma, Hepatocellular; Cell Separation; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycoproteins; Homeodomain Proteins; Humans; Inhibitory Concentration 50; Liver Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Nanog Homeobox Protein; Neoplastic Stem Cells; Niacinamide; Oncogenes; Peptides; Phenylurea Compounds; Phosphoproteins; RNA-Binding Proteins; RNA, Small Interfering; Signal Transduction; Sirolimus; Smad Proteins; Sorafenib; Spheroids, Cellular; Toll-Like Receptor 4; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; YAP-Signaling Proteins

2013
Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Liver Neoplasms; MAP Kinase Signaling System; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Transforming Growth Factor beta; Treatment Failure; Treatment Outcome; Valproic Acid

2014
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.
    International journal of cancer, 2015, Feb-15, Volume: 136, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Hep G2 Cells; Humans; Hyaluronan Receptors; Liver Neoplasms, Experimental; Mice, Nude; Niacinamide; Phenotype; Phenylurea Compounds; Sorafenib; Transforming Growth Factor beta; Xenograft Model Antitumor Assays

2015
Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Actins; Animals; Apoptosis; Cadherins; Cell Line; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Immunohistochemistry; Kidney Diseases; Male; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Rats; Smad3 Protein; Sorafenib; Transforming Growth Factor beta; Ureteral Obstruction

2015
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Journal of immunology (Baltimore, Md. : 1950), 2015, Oct-01, Volume: 195, Issue:7

    Topics: Animals; Antineoplastic Agents; CD40 Ligand; Cell Proliferation; CTLA-4 Antigen; Female; Forkhead Transcription Factors; Humans; Immunotherapy; Interferon-gamma; Interleukin-17; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Jurkat Cells; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms; NFATC Transcription Factors; Niacinamide; Ovalbumin; Peptide Fragments; Phenylurea Compounds; Promoter Regions, Genetic; Receptors, Antigen, T-Cell; Sorafenib; T-Lymphocytes, Regulatory; Transforming Growth Factor beta

2015
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
    Journal of molecular medicine (Berlin, Germany), 2016, Volume: 94, Issue:10

    Topics: Adult; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Humans; Keloid; Male; Middle Aged; Mitogen-Activated Protein Kinases; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Signal Transduction; Sincalide; Smad Proteins; Sorafenib; Transforming Growth Factor beta; Young Adult

2016
TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Liver; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Pyrazoles; Quinolines; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sorafenib; Transforming Growth Factor beta

2017
Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
    Yonsei medical journal, 2017, Volume: 58, Issue:5

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Niacinamide; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Phosphorylation; RNA, Small Interfering; Signal Transduction; Sorafenib; Transforming Growth Factor beta; Xenograft Model Antitumor Assays

2017
Alpha mangostin Inhibits Hepatic Stellate Cells Activation Through TGF-β/Smad and Akt Signaling Pathways: An in vitro Study in LX2.
    Drug research, 2018, Volume: 68, Issue:3

    Topics: Actins; Animals; Biomarkers; Cell Proliferation; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Ki-67 Antigen; Male; Niacinamide; Phenylurea Compounds; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Smad3 Protein; Sorafenib; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Xanthones

2018
Nicotinamide riboside protects against liver fibrosis induced by CCl
    Life sciences, 2019, May-15, Volume: 225

    Topics: Acetylation; Animals; Carbon Tetrachloride; E1A-Associated p300 Protein; Gene Expression Regulation; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Niacinamide; Protective Agents; Pyridinium Compounds; Sirtuin 1; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta

2019
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:6

    Topics: Animals; Apoptosis; Cell Line; Chemokine CCL2; Disease Models, Animal; Fibrosis; Inflammation; Interleukin-1beta; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Inbred C57BL; Niacinamide; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ureteral Obstruction

2019
Nicaraven mitigates radiation-induced lung injury by downregulating the NF-κB and TGF-β/Smad pathways to suppress the inflammatory response.
    Journal of radiation research, 2022, Mar-17, Volume: 63, Issue:2

    Topics: Animals; Humans; Lung; Lung Injury; Mice; Mice, Inbred C57BL; NF-kappa B; Niacinamide; Transforming Growth Factor beta

2022
In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells.
    Scientific reports, 2022, 06-01, Volume: 12, Issue:1

    Topics: Animals; Cell Differentiation; Dogs; Insulin; Mesenchymal Stem Cells; Niacinamide; Phosphatidylinositol 3-Kinases; Taurine; Transforming Growth Factor beta

2022
Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice.
    Nutrients, 2023, Mar-17, Volume: 15, Issue:6

    Topics: Animals; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; NAD; Niacinamide; Transforming Growth Factor beta

2023
chemdatabank.com